Amino Acids Quantitative by LC-MS/MS, Plasma
Amino acids are organic compounds that contain both an amino group (–NH2) and a carboxyl group (–COOH). Although more than 300 different amino acids are found in nature, only 20 of them function as building blocks in the synthesis of proteins. Apart from the protein synthesis, amino acids also serve as precursors for the synthesis of various specialized molecules like porphyrins, lipids, signaling molecules, neurotransmitters, hormones, melanin, creatine, purines, and pyrimidines. In general, during degradation of amino acids, the amino group is released as ammonia, which is later detoxified to urea in the liver, and the carbon skeleton can be used to generate either glucose or acetyl coenzyme A.
Free amino acids are present throughout the cells and extracellular fluids. This pool of amino acids is supplied by three sources: 1) amino acids provided by turnover of proteins, 2) dietary amino acids, and 3) nonessential amino acids synthesized by the body. Inborn errors of amino acids metabolism are associated with its impaired metabolism resulting in accumulation of harmful metabolites or deficiency of important products. The toxic accumulation of metabolites results various clinical symptoms, most importantly intellectual disability and developmental delay. More than 50 of such disorders of amino acid metabolism have been described. Some of the important inherited diseases of amino acid metabolism includes cystinuria, histidinemia, phenylketonuria (PKU), methylmalonyl CoA mutase deficiency, albinism, homocystinuria, alkaptonuria, maple syrup urine disease (MSUD), and tyrosinemia. Confirmatory and prenatal diagnosis of each of these disorders can be done by molecular testing to detect the specific mutation in the involved gene.
The clinical presentation depends on the specific amino acid disorder. Generalized clinical findings include failure to thrive, neurological manifestations, intellectual and cognitive impairments, digestive problems, and dermatological problem. If not diagnosed and managed promptly, many of these disorders result in severe mental retardation and death. For example, PKU is one of the common clinically encountered inherited metabolic disease of amino acid metabolism (1:15,000 live birth) and is due to a deficiency of phenylalanine hydroxylase. in PKU, phenylalanine is not converted to tyrosine resulting in the accumulation of phenylalanine, which is diverted to produce various phenylketone metabolites. It is characterized by various CNS symptoms, including severe intellectual disability, developmental delay, microcephaly, and seizures. Diagnosis and screening can be done by demonstrating elevated blood level of phenylalanine in blood and/or elevated urinary excretion of phenylalanine, phenylpyruvate, phenylacetone, and phenyllactate.
- Useful in the diagnosis and monitoring of inherited metabolic disorders related to amino acid metabolism including phenylketonuria, tyrosinemia, alkaptonuria, ciltrullinemia, arginosuccinic aciduria, hyperammonaemia, maple syrup urine disease (MSUD)
- Urine amino acid profile is useful in screening for disorders in amino acid transportation e.g, cystinuria, Hartnup disease, lysinuric protein intolerance, iminoglycinuria etc
- CSF amino acid profiling is useful in the diagnosis of certain neurotransmitter disorders including glycine encephalopathy, brain serine deficiency
- Aid in the evaluation of various disorder of muscles, liver, endocrine glands, kidney, neoplastic diseases, and nutritional disturbances
| Component | 0–30 days | 1 month–11 months | 1 year and older |
| Alpha-aminoadipic acid | 0 - 4 µmol/L | 0 - 3 µmol/L | 0 - 3 µmol/L |
| Alpha-amino butyric acid | 0 - 40 µmol/L | 0 - 40 µmol/L | 0 - 30 µmol/L |
| Alanine | 130 - 560 µmol/L | 150 - 570 µmol/L | 150 - 570 µmol/L |
| Allo-isoleucine | 0 - 5 µmol/L | 0 - 3 µmol/L | 0 - 3 µmol/L |
| Anserine | 0 - 2 µmol/L | 0 - 2 µmol/L | 0 - 2 µmol/L |
| Arginine | 15 - 160 µmol/L | 20 -160 µmol/L | 40 - 160 µmol/L |
| Argininosuccinic Acid | 0 - 2 µmol/L | 0 - 2 µmol/L | 0 - 2 µmol/L |
| Asparagine | 20 - 80 µmol/L | 30 - 80 µmol/L | 30 - 80 µmol/L |
| Aspartic Acid | 5 - 50 µmol/L | 0 - 40 µmol/L | 0 - 25 µmol/L |
| Beta-alanine | 0 - 20 µmol/L | 0 - 20 µmol/L | 0 - 20 µmol/L |
| Beta-amino isobutyric acid | 0 -10 µmol/L | 0 -10 µmol/L | 0 - 5 µmol/L |
| Citrulline | 5-50 µmol/L | 5-50 µmol/L | 10-60 µmol/L |
| Cystathionine | 0 -10 µmol/L | 0 - 5 µmol/L | 0 - 5 µmol/L |
| Cystine | 5-50 µmol/L | 7-50 µmol/L | 7-70 µmol/L |
| Ethanolamine | 0 - 40 µmol/L | 0 - 20 µmol/L | 0 - 15 µmol/L |
| Gamma-amino butyric acid | 0 - 2 µmol/L | 0 - 2 µmol/L | 0 - 2 µmol/L |
| Glutamic Acid | 50 - 300 µmol/L | 25 - 200 µmol/L | 10 - 120 µmol/L |
| Glutamine | 285 - 950 µmol/L | 410 - 900 µmol/L | 410 - 700 µmol/L |
| Glycine | 150 - 500 µmol/L | 120 - 450 µmol/L | 120 - 450 µmol/L |
| Histidine | 50 - 110 µmol/L | 50 - 110 µmol/L | 50 - 110 µmol/L |
| Homocitrulline | 0 - 5 µmol/L | 0 - 3 µmol/L | 0 - 2 µmol/L |
| Homocystine | 0 - 2 µmol/L | 0 - 2 µmol/L | 0 - 2 µmol/L |
| Hydroxylysine | 0 - 5 µmol/L | 0 - 5 µmol/L | 0 - 5 µmol/L |
| Hydroxyproline | 0 - 100 µmol/L | 0 - 90 µmol/L | 0 - 55 µmol/L |
| Isoleucine | 20 - 130 µmol/L | 20 - 130 µmol/L | 30 - 130 µmol/L |
| Leucine | 50 - 200 µmol/L | 50 - 200 µmol/L | 60 - 230 µmol/L |
| Lysine | 60 - 300 µmol/L | 60 - 280 µmol/L | 80 - 250 µmol/L |
| Methionine | 10 - 60 µmol/L | 10 - 60 µmol/L | 14 - 50 µmol/L |
| Ornithine | 30 - 200 µmol/L | 20 - 160 µmol/L | 20 - 135 µmol/L |
| Phenylalanine | 30 - 100 µmol/L | 30 - 90 µmol/L | 30 - 80 µmol/L |
| Proline | 100-400 µmol/L | 80-400 µmol/L | 80-400 µmol/L |
| Sarcosine | 0 - 5 µmol/L | 0 - 5 µmol/L | 0 - 5 µmol/L |
| Serine | 90 - 300 µmol/L | 90 - 300 µmol/L | 60 - 200 µmol/L |
| Taurine | 25 - 300 µmol/L | 25 - 220 µmol/L | 25 -150 µmol/L |
| Threonine | 50 - 400 µmol/L | 50 - 300 µmol/L | 60 - 200 µmol/L |
| Tryptophan | 15 - 90 µmol/L | 15 - 90 µmol/L | 30 - 100 µmol/L |
| Tyrosine | 30 - 140 µmol/L | 30 - 140 µmol/L | 30 - 120 µmol/L |
| Valine | 80 - 300 µmol/L | 80 - 300 µmol/L | 100 - 300 µmol/L |
Plasma (heparin); fasting in Adult, fasting or 2-3 hours following meal in infants and children. Separate plasma within 2 hours of blood collection.
Stability
- Ambient: 2-3 days
- Refrigerated: 7 days
Urine (random) and/or CSF.
Stability
- Refrigerated: 24 hours
- Frozen: 1 month
Hereditary Peripheral Neuropathies Gene Mutation Panel, NGS, Comprehensive metabolic panel, Vitamin D, Folic Acid.
- Rapid Commun Mass Spectrom 2008;22:3481–8 [PMID: 18853396]
- Clin Chem Lab Med 2000;38:391–401 [PMID: 10952221]
- Rapid Commun Mass Spectrom 2003;17:983–90 [PMID: 12717773]
- Ann Clin Lab Sci. 1991 Mar-Apr;21(2):123-42. [PMID: 2029175]